CHU de Brest - Hopital de la Cavale Blanche — Brest

Public research footprint of CHU de Brest - Hopital de la Cavale Blanche, compiled from the ClinicalTrials.gov public registry.

Registered studies

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Carcinoma, Non-Small-Cell Lung · Chronic Thromboembolic Pulmonary Hypertension · Atrial Fibrillation · Ischemic Stroke; Ischemic Attack, Transient

Recently updated registry entries

NCT07623200 — A Phase 3 Study of INCA033989 Versus Best Available Therapy in Participants With… (Recruiting)
NCT05702034 — A Study of Milvexian in Participants After an Acute Ischemic Stroke or High-Risk… (Active Not Recruiting)
NCT05663866 — Premedication to Reduce Amivantamab Associated Infusion Related Reactions (Active Not Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at CHU de Brest - Hopital de la Cavale Blanche?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 06, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.